These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 30825)

  • 1. "Antagonist"-precipitated withdrawal in the rat after chronic delta9-tetrahydrocannabinol treatment.
    Taylor DA; Fennessy MR
    J Pharm Pharmacol; 1978 Oct; 30(10):654-6. PubMed ID: 30825
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism of the effects on thermoregulation of delta9-tetrahydrocannabinol by clomipramine in the rat.
    Fennessy MR; Taylor DA
    Br J Pharmacol; 1978 Jun; 63(2):267-73. PubMed ID: 667419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-course of the effects of chronic delta 9-tetrahydrocannabinol on behaviour, body temperature, brain amines and withdrawal-like behaviour in the rat.
    Taylor DA; Fennessy MR
    J Pharm Pharmacol; 1982 Apr; 34(4):240-5. PubMed ID: 6124598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of delta 9-tetrahydrocannabinol-induced withdrawal-like behaviour by delta 9-tetrahydrocannabinol.
    Verberne AJ; Taylor DA; Fennessy MR
    Psychopharmacology (Berl); 1981; 73(1):97-8. PubMed ID: 6262850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol.
    Cook SA; Lowe JA; Martin BR
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1150-6. PubMed ID: 9618417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic delta9-tetrahydrocannabinol in rats: effect on social interactions, mouse killing, motor activity, consummatory behavior, and body temperature.
    Miczek KA
    Psychopharmacology (Berl); 1979 Jan; 60(2):137-46. PubMed ID: 106423
    [No Abstract]   [Full Text] [Related]  

  • 7. Withdrawal-like behaviour induced by inhibitors of biogenic amine reuptake in rats treated chronically with delta 9-tetrahydrocannabinol.
    Verberne AJ; Taylor DA; Fennessy MR
    Psychopharmacology (Berl); 1980; 68(3):261-7. PubMed ID: 6248916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental evaluation of the possible neuroleptic activity of clomipramine.
    Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1978; 22(3):263-9. PubMed ID: 31334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol.
    Tanda G; Loddo P; Di Chiara G
    Eur J Pharmacol; 1999 Jul; 376(1-2):23-6. PubMed ID: 10440085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and biochemical effects of chronic delta 9-tetrahydrocannabinol in rats.
    Miczek KA; Dixit BN
    Psychopharmacology (Berl); 1980 Feb; 67(2):195-202. PubMed ID: 6245424
    [No Abstract]   [Full Text] [Related]  

  • 11. Biphasic nature of the effects of delta9-tetrahydrocannabinol on body temperature and brain amines of the rat.
    Taylor DA; Fennessy MR
    Eur J Pharmacol; 1977 Nov; 46(2):93-9. PubMed ID: 590330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of SR 141716A after acute or chronic cannabinoid administration in dogs.
    Lichtman AH; Wiley JL; LaVecchia KL; Neviaser ST; Arthur DB; Wilson DM; Martin BR
    Eur J Pharmacol; 1998 Sep; 357(2-3):139-48. PubMed ID: 9797029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of delta9-tetrahydrocannabinol on body temperature and brain amine concentrations in the rat at differnt ambient temperatures.
    Fennessy MR; Taylor DA
    Br J Pharmacol; 1977 May; 60(1):65-71. PubMed ID: 884391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic effects of morphine and withdrawal from morphine on temperature in the cat.
    French ED; Vasquez SA; George R
    Proc West Pharmacol Soc; 1976; 19():273-7. PubMed ID: 1033555
    [No Abstract]   [Full Text] [Related]  

  • 15. Mianserin, danitracen and amitriptyline withdrawal increases the behavioural responses of rats to L-5-HTP.
    Mogilnicka E; Klimek V
    J Pharm Pharmacol; 1979 Oct; 31(10):704-5. PubMed ID: 41046
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of chronic imipramine and clomipramine oral administration on maternal behavior and litter development.
    Broitman ST; Donoso AO
    Psychopharmacology (Berl); 1978 Jan; 56(1):93-101. PubMed ID: 415332
    [No Abstract]   [Full Text] [Related]  

  • 17. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
    Neal BS; Sparber SB
    J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of naloxone-induced withdrawal in morphine dependent mice by 1-trans-delta9-tetrahydrocannabinol.
    Bhargava HN
    Eur J Pharmacol; 1976 Mar; 36(1):259-62. PubMed ID: 944134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.
    Frederickson RC; Hewes CR; Aiken JW
    J Pharmacol Exp Ther; 1976 Nov; 199(2):375-84. PubMed ID: 988178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and subacute interactions between delta9-tetrahydrocannabinol and other drugs in the rat.
    Pryor GT; Husain S; Mitoma C
    Ann N Y Acad Sci; 1976; 281():171-89. PubMed ID: 1071364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.